“…28,45 Preparative scale microtransformation of yakuchinone A (4) was performed with Mucor hiemalis to study the structure-activity relationship of yakuchinone A derivatives against HT-29 cancer cells. 49 Eight new metabolites were isolated from the sample: (3S)-oxyphyllacinol (56), (3S)-7-hydroxyoxyphyllacinol (57), (3S)-2 00 -hydroxyoxyphyllacinol (58), (3S)-3 00hydroxyoxyphyllacinol ( 59), (3S)-4 00 -hydroxyoxyphyllacinol (60), Name No. Name 1,7-Diphenylheptan-3-one 25 38 (5S)-5-Methoxy-1,7-diphenylhepta-6-en-3-one 22 7-(4 00 -Hydroxy-3 00 -methoxyphenyl)-1-phenylheptan-3-one 41 39 trans-(4R,5S)-Epoxy-1,7-diphenylheptan-3-one 45 7-(4 00 -Actetoxy-3 00 -methoxy phenyl)-1-phenylheptan-3-one 41 40 1,7-Diphenylhept-5-en-3-one 45 Yakuchinone A 49,50 41 (4E,6E)-7-(4 00 -Hydroxy-3 00 -methoxyphenyl)-1-phenylhepta-4,6-dien-3-one 45 5 0 -Hydroxyyakuchinone A 50 42 (3S,5S,6S)-1-(4 0 -Hydroxy-3 0 -methoxyphenyl)-7phenylheptane-3,5,6-triol 25 1,7-Diphenylheptane-3,5-dione 25 43 1,7-Diphenylheptane-3,5-diol 25,68 1-(3 0 ,4 0 -Dihydroxyphenyl)-7-phenylheptane-3,5-dione 25 44 1-(4 0 -Hydroxyphenyl)-7-phenylheptane-3,5-diol 25 1-(4 0 -Hydroxy-3 0 -methoxyphenyl)-7-phenylheptane-3,5dione 25…”